跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,805 条关于
“DV-10”
全部
12,805
临床试验
4,458
药物
1,146
机构
153
资讯
7,048
上个月
Dispatch Bio Doses First Patient in Phase 1 Trial of DISP-10, a Novel Synthetic-Antigen CAR T Immunotherapy for Advanced GI Cancers, Secures FDA Fast Track Designation
6年前
Butantan-DV Dengue Vaccine Shows Promising Safety and Immunogenicity in Phase 2 Trial
去年
Disitamab Vedotin Shows Promise in HER2-Positive Breast Cancer with Liver Metastasis
去年
Disitamab Vedotin Plus Toripalimab Shows Promise in Muscle-Invasive Bladder Cancer
去年
Phase II Trial Shows Breakthrough 63.6% Response Rate for Novel Bladder Cancer Combination Therapy
去年
Butantan Institute Seeks Approval in Brazil for Single-Dose Dengue Vaccine
去年
Dengue Vaccine Landscape Evolves: New Candidates Show Promise in Clinical Trials
5年前
FDA Approves Remdesivir as First Official COVID-19 Treatment
6个月前
Brazilian Single-Dose Dengue Vaccine Shows 80.5% Efficacy Against Hospitalization in Five-Year Phase 3 Trial
去年
FDA Approves Genentech's Itovebi for Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation
第 1 页,共 705 页
上一页
下一页